Ameriprise’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-116,422
| Closed | -$1.76M | – | 4102 |
|
|
2022
Q3 | $1.76M | Sell |
116,422
-1,302,754
| -92% | -$15.1M | ﹤0.01% | 2840 |
|
|
2022
Q2 | $10.6M | Buy |
1,419,176
+871
| +0.1% | +$6.14K | ﹤0.01% | 1695 |
|
|
2022
Q1 | $12.9M | Sell |
1,418,305
-610,482
| -30% | -$4.71M | ﹤0.01% | 1691 |
|
|
2021
Q4 | $14.2M | Buy |
2,028,787
+407,457
| +25% | +$4.26M | ﹤0.01% | 1676 |
|
|
2021
Q3 | $18.5M | Buy |
1,621,330
+51,586
| +3% | +$754K | 0.01% | 1324 |
|
|
2021
Q2 | $25.1M | Sell |
1,569,744
-21,388
| -1% | -$367K | 0.01% | 1184 |
|
|
2021
Q1 | $28.4M | Buy |
1,591,132
+223,648
| +16% | +$3.86M | 0.01% | 1066 |
|
|
2020
Q4 | $18.5M | Buy |
1,367,484
+255,354
| +23% | +$3.09M | 0.01% | 1280 |
|
|
2020
Q3 | $13.1M | Buy |
1,112,130
+276,055
| +33% | +$3.36M | 0.01% | 1362 |
|
|
2020
Q2 | $12.3M | Sell |
836,075
-329,946
| -28% | -$4.88M | 0.01% | 1373 |
|
|
2020
Q1 | $15.7M | Buy |
1,166,021
+54,085
| +5% | +$1.03M | 0.01% | 1089 |
|
|
2019
Q4 | $26.9M | Buy |
1,111,936
+144,698
| +15% | +$3M | 0.01% | 995 |
|
|
2019
Q3 | $18.6M | Buy |
967,238
+458,876
| +90% | +$10.5M | 0.01% | 1198 |
|
|
2019
Q2 | $15M | Buy |
508,362
+109,298
| +27% | +$4.21M | 0.01% | 1391 |
|
|
2019
Q1 | $19M | Sell |
399,064
-12,807
| -3% | -$564K | 0.01% | 1185 |
|
|
2018
Q4 | $14.9M | Buy |
411,871
+78,095
| +23% | +$3.66M | 0.01% | 1270 |
|
|
2018
Q3 | $20.3M | Buy |
333,776
+13,181
| +4% | +$847K | 0.01% | 1284 |
|
|
2018
Q2 | $21.6M | Buy |
320,595
+40,717
| +15% | +$2.28M | 0.01% | 1111 |
|
|
2018
Q1 | $15.2M | Sell |
279,878
-15,524
| -5% | -$868K | 0.01% | 1331 |
|
|
2017
Q4 | $17.6M | Buy |
295,402
+5,525
| +2% | +$335K | 0.01% | 1157 |
|
|
2017
Q3 | $14.1M | Sell |
289,877
-4,050
| -1% | -$221K | 0.01% | 1312 |
|
|
2017
Q2 | $15.4M | Sell |
293,927
-64,240
| -18% | -$2.99M | 0.01% | 1218 |
|
|
2017
Q1 | $16.2M | Sell |
358,167
-109,659
| -23% | -$4.89M | 0.01% | 1164 |
|
|
2016
Q4 | $17.7M | Sell |
467,826
-127,466
| -21% | -$4.82M | 0.01% | 1082 |
|
|
2016
Q3 | $22.5M | Buy |
595,292
+438,563
| +280% | +$9.67M | 0.01% | 866 |
|
|
2016
Q2 | $2.76M | Sell |
156,729
-13,345
| -8% | -$216K | ﹤0.01% | 2353 |
|
|
2016
Q1 | $2.07M | Sell |
170,074
-1,889
| -1% | -$29.9K | ﹤0.01% | 2493 |
|
|
2015
Q4 | $4.19M | Sell |
171,963
-75,446
| -30% | -$1.76M | ﹤0.01% | 2152 |
|
|
2015
Q3 | $4.39M | Sell |
247,409
-97,520
| -28% | -$1.77M | ﹤0.01% | 2101 |
|
|
2015
Q2 | $6.09M | Buy |
344,929
+237,627
| +221% | +$4.36M | ﹤0.01% | 2001 |
|
|
2015
Q1 | $3.36M | Buy |
107,302
+66,334
| +162% | +$1.92M | ﹤0.01% | 2315 |
|
|
2014
Q4 | $1.2M | Buy |
40,968
+2,172
| +6% | +$55.1K | ﹤0.01% | 2795 |
|
|
2014
Q3 | $803K | Buy |
+38,796
| New | +$765K | ﹤0.01% | 2890 |
|
Ameriprise's AERI Position: Q4 2022 in Review
Ameriprise sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 116,422 shares — an estimated $1.76M sold.
Ameriprise first reported a position in AERI in Q3 2014 and held it in 33 quarters. The position peaked at $28.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Ameriprise reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Ameriprise sold 116,422 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.76M.
- Ameriprise first reported a position in Aerie Pharmaceuticals in Q3 2014 and held it in 33 quarters.
- Ameriprise's Aerie Pharmaceuticals position peaked at $28.4M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.